Guangzhou Baiyunshan Phar... (GZPHF)
Guangzhou Baiyunshan Pharmaceutical Statistics
Share Statistics
Guangzhou Baiyunshan Pharmaceutical has 2.55B shares outstanding. The number of shares has increased by 5.04% in one year.
| Shares Outstanding | 2.55B |
| Shares Change (YoY) | 5.04% |
| Shares Change (QoQ) | -1.22% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.55B |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 12.05 and the forward PE ratio is null. Guangzhou Baiyunshan Pharmaceutical's PEG ratio is -0.4.
| PE Ratio | 12.05 |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| Forward PS | n/a |
| PB Ratio | 0.95 |
| P/FCF Ratio | 14.77 |
| PEG Ratio | -0.4 |
Enterprise Valuation
Guangzhou Baiyunshan Pharmaceutical has an Enterprise Value (EV) of 28.28B.
| EV / Sales | 0.38 |
| EV / EBITDA | 5.77 |
| EV / EBIT | 8.21 |
| EV / FCF | 12.22 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.48 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 2.52 |
| Debt / FCF | 5.35 |
| Interest Coverage | 8.6 |
Financial Efficiency
Return on Equity is 7.9% and Return on Invested Capital is 5.76%.
| Return on Equity | 7.9% |
| Return on Assets | 3.47% |
| Return on Invested Capital | 5.76% |
| Revenue Per Employee | $2.67M |
| Profits Per Employee | $100.77K |
| Employee Count | 28,138 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 4.88 |
Taxes
| Income Tax | 606.85M |
| Effective Tax Rate | 16.82% |
Stock Price Statistics
The stock price has increased by -21.87% in the last 52 weeks. The beta is 0.52, so Guangzhou Baiyunshan Pharmaceutical's price volatility has been higher than the market average.
| Beta | 0.52 |
| 52-Week Price Change | -21.87% |
| 50-Day Moving Average | 2.5 |
| 200-Day Moving Average | 2.78 |
| Relative Strength Index (RSI) | 0 |
| Average Volume (20 Days) | 508 |
Income Statement
In the last 12 months, Guangzhou Baiyunshan Pharmaceutical had revenue of 74.99B and earned 2.84B in profits. Earnings per share was 1.74.
| Revenue | 74.99B |
| Gross Profit | 12.52B |
| Operating Income | 3.6B |
| Net Income | 2.84B |
| EBITDA | 4.9B |
| EBIT | 4.03B |
| Earnings Per Share (EPS) | 1.74 |
Balance Sheet
The company has 18.27B in cash and 12.37B in debt, giving a net cash position of 5.9B.
| Cash & Cash Equivalents | 18.27B |
| Total Debt | 12.37B |
| Net Cash | 5.9B |
| Retained Earnings | 21.82B |
| Total Assets | 81.68B |
| Working Capital | 18.85B |
Cash Flow
In the last 12 months, operating cash flow was 3.44B and capital expenditures -1.13B, giving a free cash flow of 2.31B.
| Operating Cash Flow | 3.44B |
| Capital Expenditures | -1.13B |
| Free Cash Flow | 2.31B |
| FCF Per Share | 1.42 |
Margins
Gross margin is 16.7%, with operating and profit margins of 4.8% and 3.78%.
| Gross Margin | 16.7% |
| Operating Margin | 4.8% |
| Pretax Margin | 4.81% |
| Profit Margin | 3.78% |
| EBITDA Margin | 6.54% |
| EBIT Margin | 4.8% |
| FCF Margin | 3.09% |
Dividends & Yields
GZPHF pays an annual dividend of $0.16, which amounts to a dividend yield of 1.98%.
| Dividend Per Share | $0.16 |
| Dividend Yield | 1.98% |
| Dividend Growth (YoY) | 1.51% |
| Payout Ratio | 67.59% |
| Earnings Yield | 8.3% |
| FCF Yield | 6.77% |
Analyst Forecast
Currently there are no analyst rating for GZPHF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 28, 2014. It was a forward split with a ratio of 10031:10000.
| Last Split Date | Jan 28, 2014 |
| Split Type | forward |
| Split Ratio | 10031:10000 |
Scores
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 3 |